Digital therapies are proving particularly useful in pathological conditions linked to behavioural and psychological factors, such as Alzheimer’s, dementia, type II diabetes, and even serious respiratory problems. Let’s take a look at how they are made, how they work, the indications and market perspectives.
The FDA has awarded De Novo certification to NigthWare which has developed a digital therapy to combat sleep disorders.
According to a Juniper Research study, the number of people using therapeutic and wellness applications will increase from 627 million in 2020 to more than 1.4 billion in 2025.
Eleven months after the approval of the Digital Versorgung Gesetz (DVG), the Digital Health Care Act (DVG), two apps are now prescribed by German doctors.
Akili Interactive has received De Novo marketing authorization from the FDA for EndeavorRx, a therapeutic video game for children aged 8-12 years with ADHD (Attention Deficit Disorder/Hyperactivity Disorder).
Digital-health 